GOLDMAN SACHS GROUP INC - 31 Mar 2025 SCHEDULE 13G/A Report for SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0001 per share (SLXN)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0001 per share
Symbol
SLXN
Shares outstanding
8.83M shares
Disclosed Ownership
212K shares
Ownership
2.4%
Form type
SCHEDULE 13G/A
Filing time
13 May 2025, 11:36:32 UTC
Date of event
31 Mar 2025
Previous filing
10 Feb 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 2.4% 212K 0 212K Name: Sam Prashanth Attorney-in-fact
GOLDMAN SACHS & CO. LLC 2.4% 212K 0 212K Name: Sam Prashanth Attorney-in-fact